Cite
Investigation of the unique metabolic fate of ethyl (6R)-6- [N- (2-chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242) in rats and dogs using two types of 14C-labeled compounds having different labeled positions.
MLA
Jinno, Fumihiro, et al. “Investigation of the Unique Metabolic Fate of Ethyl (6R)-6- [N- (2-Chloro-4-Fluorophenyl) Sulfamoyl] Cyclohex-1-Ene-1-Carboxylate (TAK-242) in Rats and Dogs Using Two Types of 14C-Labeled Compounds Having Different Labeled Positions.” Arzneimittel-Forschung, vol. 61, no. 8, 2011, pp. 458–71. EBSCOhost, https://doi.org/10.1055/s-0031-1296228.
APA
Jinno, F., Kakehi, M., Takeuchi, T., Tagawa, Y., Kondo, T., & Asahi, S. (2011). Investigation of the unique metabolic fate of ethyl (6R)-6- [N- (2-chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242) in rats and dogs using two types of 14C-labeled compounds having different labeled positions. Arzneimittel-Forschung, 61(8), 458–471. https://doi.org/10.1055/s-0031-1296228
Chicago
Jinno, Fumihiro, Masaaki Kakehi, Toshiyuki Takeuchi, Yoshihiko Tagawa, Takahiro Kondo, and Satoru Asahi. 2011. “Investigation of the Unique Metabolic Fate of Ethyl (6R)-6- [N- (2-Chloro-4-Fluorophenyl) Sulfamoyl] Cyclohex-1-Ene-1-Carboxylate (TAK-242) in Rats and Dogs Using Two Types of 14C-Labeled Compounds Having Different Labeled Positions.” Arzneimittel-Forschung 61 (8): 458–71. doi:10.1055/s-0031-1296228.